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THE GUT-BRAIN AXIS AND COGNITION  
SOPHIA ANGELIDES 
ABSTRACT 
 The gut and the brain are in constant communication through pathways 
that include the immune system, the nervous system, neurotransmitters, and 
hormones. Modifications in the gut, especially the gut microbiome, have the 
potential to cause changes in the brain resulting in behavioral and cognitive 
changes. A healthy and diverse microbiome, which may be achieved by a high 
fiber diet or probiotic or prebiotic treatments, is associated with improvements in 
cognition. Gut dysbiosis and a decrease in diversity of the microbiota, which may 
be caused by a western diet or antibiotic treatments, is associated with cognitive 
decline and decreased memory. There are many possible pathways through 
which these changes in the gut act to change cognition, including the immune 
system, the expression of brain derived neurotropic factor, metabolites such as 
short chain fatty acids, gut hormones, and neurotransmitters. If researchers can 
decipher which pathways are involved in modifying cognition, they may be able 
to identify treatments that can help improve memory and specifically decrease 
age-related cognitive decline.    
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INTRODUCTION 
The gut-brain axis (GBA) is a pathway of bidirectional communication 
between the gastrointestinal (GI) system and the central nervous system CNS. 
The gut and the brain are connected through numerous bidirectional 
communication pathways and are believed to largely communicate through 
immune, microbial, neural, and hormonal signals, which will be detailed in this 
thesis (Lyte and Cryan; Moise, The Gut Microbiome.). The GBA is sometimes 
referred to as the microbiota-gut-brain axis, as there is extensive evidence that 
the gut microbiome is related to brain health (Lyte and Cryan; Matsumoto et al., 
2013; Moise, The Gut Microbiome.). Germ free (GF) mice, which are born and 
raised in sterile environments and used as animal models of a simplified or 
absent microbiome, have abnormally developed nervous systems, which indicate 
that the microbiome is essential for brain development (Moise, The Gut 
Microbiome.). As the gut and the brain are in constant communication, changes 
in the gut result in neural changes including behavioral and cognitive changes.  
The human microbiome consists of all the non-human microorganisms 
that reside in the human body. These organisms are most numerously found in 
the gastrointestinal system, where an estimated one hundred trillion bacteria 
reside, forming a very densely populated ecosystem (Lyte and Cryan). The gut 
flora communicate with the brain using the immune system, the endocrine 
system, and the nervous system, and changes in both diversity and composition 
of the gut flora are known to be related to neurological conditions and can 
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change brain activity. Lack of gut flora diversity is associated with inflammatory 
and neurological diseases, while a rich diversity is associated with overall 
wellbeing (Lyte and Cryan; Hsiao et al., 2013; Tillisch et al., 2013). Additionally, 
dysbiosis of the gut flora is associated with dysregulation of the immune system, 
while promotion of beneficial gut microbiota is associated with improved immune 
function (Konieczna et al., 2012; Lyte and Cryan; Toumi et al., 2013). 
Additionally, problems that are classically thought to affect the brain, such as 
stress, have been seen to influence, and be influenced by the immune system 
and the GI system (Bailey et al., 2010; Lyte and Cryan). Mice that are exposed to 
stress show significantly more unwanted GI bacterial overgrowth and greater 
susceptibility to infection (Bailey et al., 2010). Conversely, pretreatment with 
probiotics, which are thought to modify the gut microbiome in a positive way, 
prevents this susceptibility to infection after stress (Zareie et al., 2006). These 
studies demonstrate the bidirectional nature of the GBA. Stress is also related to 
cognition, and, even a single incidence of stress can reduce spatial and non-
spatial memory in rodents and cognition is greatly affected by changes 
modifications of the microbiota-gut-brain axis (Wagner et al., 2013). For example, 
probiotic treatment in healthy individuals improves cognitive effort and problem 
solving skills (Messaoudi et al., 2011), while high levels of lactic acid, a 
metabolite from gut bacterial fermentation, can be associated with memory loss, 
gut permeability, and systemic inflammation (Moise, The Gut Microbiome.). 
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Modifications of the gut microbiome effect memory and cognition through 
complicated processes, including the immune system.          
The gut and brain also communicate through neuronal signals, specifically 
the enteric nervous system (ENS) and the vagus nerve. The enteric nervous 
system, a branch of the nervous system in the GI tract, is partially responsible for 
regulation of the GI tract as well as communication between the gut microbiome 
and the brain. Excitability of intrinsic primary afferent neurons (IPANs), the major 
sensory neurons of the ENS, is modified with a modification of the gut microbiota 
(Lyte and Cryan; Neufeld et al., 2012). IPANs in GF mice have significantly 
reduced intrinsic excitability compared to controls, while rats treated with 
probiotics show and increase in intrinsic excitability of IPANs (Kunze et al., 2009; 
Neufeld et al., 2012). This relationship between change in excitability of ENS 
neurons and the change in the gut microbiome highlight the ENS as a key 
pathway of communication between the GI system and the central nervous 
system.  
The vagus nerve is the other main neuronal pathway through which the 
gut and the brain communicate. Infections in the gut, even in the absence of an 
overt immune response, can change behavior and brain activity via the vagus 
nerve (Goehler et al., 2014). In a mouse model of Campylocater jejuni, a GI 
infection, infected mice displayed more anxious behavior and more neuronal 
activation in the vagal sensory ganglion and the nucleus of the solitary track, 
though there was no difference in levels of inflammatory markers when 
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compared to controls (Goehler et al., 2014). Rats infected with Salmonella 
Typhimurium also show an increase in neuronal activation in the hypothalamus, 
however, this activity decreases to values of uninfected rats if the vagus nerve is 
severed subdiaphragmatically (Wang et al., 2002). Modification of the gut flora 
with probiotic treatment has also been shown to affect behavior however, these 
behavioral changes are not observed if the vagus nerve is severed (Bravo et al., 
2011). These studies highlight the fact that the vagus nerve is an important 
pathway between changes in the gut flora and the brain. Conversely, the vagus 
nerve is thought to bring information from the CNS to the GI system in a 
protective manner (Ghia et al., 2007). In a mouse model of colitis, those who had 
vagotomies showed significantly higher levels of inflammatory cytokines 
compared to mice with intact vagus nerves (Ghia et al., 2007). The vagus nerve 
is an important pathway that allows the gut and the brain to communicate 
bidirectionally.  
The last main pathway of bidirectional communication between the gut 
and the CNS is through the neuroendocrine system, via the secretion of 
neurotransmitters and hormones. The composition of the gut flora largely affects 
the composition of blood, as GF mice are known to have different concentrations 
of serum metabolites and hormones than conventional mice (Wikoff et al., 2009). 
There are many peptide hormones that are produced by enteroendocrine cells in 
the gut, whose production depends on modifications of the gut microbiome as 
well as food consumption (Lyte and Cryan; Uribe et al., 1994). While many of 
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these hormones, such as ghrelin, leptin, and gastrin, are classically thought of as 
acting in appetite control and energy homeostasis, they have more recently been 
implicated in immune responses and CNS activity including arousal, anxiety, 
stress, and cognition. This thesis will specifically analyze the role of ghrelin in 
communication between the GI system and the CNS. Levels of serum ghrelin 
increase with food restriction and may increase or decrease with a change in the 
composition and diversity of the gut flora and cause changes in CNS activity 
(Queipo-Ortuño et al., 2013). Additionally, adults with cognitive impairment have 
lower baseline levels of serum ghrelin, so it is feasible that a change in cognition, 
or the changes in CNS activity associated with cognitive decline, could down 
regulate ghrelin release (Sang et al., 2018). These changes in levels of ghrelin 
levels modulate brain activity and behavior. An increase in serum ghrelin has 
been shown to stimulate neurogenesis in the CNS and decrease inflammation, 
while a decrease in concentration has been correlated with cognitive decline and 
a decreased ability to cope with stress (Bansal et al., 2010; Lyte and Cryan). The 
gut, brain, and microbiome communicate through the gut hormone ghrelin, as 
modifications of ghrelin levels are associated with all levels of the microbiota-gut-
brain axis including the microbiome, the immune system, and CNS activity. 
The GI system and the central nervous system communicate using 
serotonin (5-HT), a neurotransmitter known to have extensive effects in both the 
central nervous system and gastrointestinal system, and whose availability varies 
with a variation in the gut microbiome (Clarke et al., 2013; Lyte and Cryan; Wikoff 
 6 
et al., 2009). The availability of serotonin in the CNS is partly due to plasma 
levels of its precursor, tryptophan. Germ free mice have increased levels of 
plasma tryptophan and a corresponding increase of hippocampal serotonin levels 
in adulthood (Clarke et al., 2013). Serum levels of tryptophan significantly 
decrease to after GF animals are colonized with bacteria (Clarke et al., 2013). 
Germ free mice also have an increased number of serotonin immunoreactive 
cells in the GI mucosa (Uribe et al., 1994). These studies on GF mice indicate 
that the gut microbiome modulates CNS serotonin availability, which is known to 
modulation mood, behavior, and cognition. Conversely, treatments that are 
known to classically treat psychiatric disorders also effectively treat GI 
symptoms. Patients with irritable bowel syndrome (IBS) who were treated with 
the selective serotonin reuptake inhibitor (SSRI) citalopram, traditionally thought 
to treat mood disorders and anxiety, showed a significant reduction of GI 
symptoms including abdominal pain, abdominal bloating, and irregular stools 
(Tack et al., 2006). Thus, the serotonergic pathway may be an important pathway 
between the gut and the brain.  
The gut-brain axis communicates through, the immune system, neural, 
and neuroendocrine pathways. Modifications or disruptions of the gut microbiome 
have been implicated in many inflammatory disorders, neurodevelopmental, and 
neurodegenerative disorders as well as mood, behavior, and cognition (Lyte and 
Cryan; Moise, The Gut Microbiome.). Decreased cognition and memory loss is a 
common complaint, especially in aging or ill populations (Tsai et al., 2018). The 
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hippocampus is highly involved in memory and learning, and decreases in 
hippocampal activity and connectivity are often associated with decreased 
cognition (Tsai et al., 2018). All levels of the GBA have been related to memory 
and cognition. A healthy gut microbiome and decreased inflammation have been 
associated with increased hippocampal neurogenesis and improved cognition, 
while dysbiosis and increased inflammation are correlated with cognitive decline. 
Cognition can be evaluated in a number of ways, which differ between animal 
and human studies. Often, animal models are subjected to behavioral tests to 
assess spatial, non-spatial, and fear dependent memory. Such behavioral tests 
are summarized in Table 1. Behavioral testing in animal models may be a good 
assessment of specific types of memory, though it may not completely translate 
to overall cognitive performance in humans (Kunath et al., 2016).  
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Table 1. Behavioral Assessments. A summary of behavioral assessments used to 
measure various kinds of memory in animal models 
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Table 1. Behavioral Assessments. A summary of behavioral assessments used to measure 
various kinds of memory in animal models   Test Method Measurements Source 
Barnes Maze Rodents are placed on a 
platform with many holes, 
one of which contains an 
escape box  
 
During a probe test, latency to find the 
hole that previously contained the 
escape box is measured. Finding the 
correct hole quickly is indicative of 
good spatial memory  
 
Corpuz et 
al., 2018 
 
Context-
Signal 
Memory  
Crabs repeatedly presented 
with visual cue that signals 
danger 
 
Decreased response to the stimulus 
when tested later shows stronger 
associative memory  
 
 
Federmean 
et al., 2009 
 
Continuous 
Multiple 
Trial 
Inhibitory 
Avoidance  
Rodents placed into a light 
box and soon after a door 
opens to reveal a dark box. 
If they step into the dark 
part of the box they receive 
a shock 
 
Quickly learning not to step into the 
dark side of the box (low number of 
trials before rodents stay in the light 
side) is indicative of intact learning and 
fear-motivated memory 
 
Wei et al., 
2015 
 
Inhibitory 
Avoidance  
 
Rodents are shocked if they 
step onto grid floor of 
training apparatus  
 
Latency to step onto grid floor in 
subsequent trials measures fear-
motivated memory  
 
Blank et al, 
2015 
 
Morris Water 
Maze  
 
Rodents swim in a large 
arena and a platform is 
consistently placed in the 
same quadrant 
 
Finding the platform quickly and 
spending more time in the quadrant 
during a probe test is indicative of 
good spatial memory  
 
 
Chunchai 
et al., 2018 
Novel Object 
Recognition 
 
Rodents are exposed to a 
novel object and an object 
with which they are familiar 
 
A preference for the novel object over 
the familiar object is indicative of good 
non-spatial memory  
 
Desbonnet 
et al., 2013 
Radial Maze  
 
A radial maze contains 
about eight arms which 
have a food reward at 
the end 
Visiting each arm only once serves 
as an indication of intact working 
memory. Visiting all the arms with 
food reward serves as an indication 
of good reference memory  
Kanoski 
and 
Davidson, 
2010 
 
T maze 
 
Rodents are placed at the 
base of a T shaped maze 
and allowed to explore 
either the left of the right 
arms before being removed 
and then placed back in the 
maze for another trial  
 
Equal exploration of both left and right 
arms is indicative of intact working 
memory 
 
Gareau et 
al., 2011 
 
Y Maze  
 
Rodents are placed in a 
maze in the shape of a Y 
and allowed to move freely  
 
An increase in alternations of visiting 
different arms is indicative of good 
spatial memory  
 
Li et al., 
2013 
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SPECIFIC AIMS 
The specific aims of this thesis are to explore the pathways of bidirectional 
communication between the gut and the brain, specifically in relation to memory 
and cognition. It will explore the communication between the gut and the brain, 
specifically assessing how changes in the gut microbiome, and its metabolites 
may affect various levels of the GBA and impact cognition. A review of possible 
mechanism through which memories are modified may provide insight into 
possible treatments for cognitive decline.    
PUBLISHED STUDIES 
The Immune System and Cognition  
 The gastrointestinal system and the central nervous system communicate 
through the immune system and inflammatory responses. Modifications of the 
intestinal microbiome have been associated with an immune response, and 
increased inflammation is associated with decreased cognition (Moise, The Gut 
Microbiome.). Germ Free mice are known to have abnormal immune systems 
such as a decrease in the size of Peyer’s patches and decreased production of 
the anti-inflammatory cytokine interleukin (IL) -10 (Moise, The Gut Microbiome.). 
Additionally, dybiosis is associated with an immune response, possibly due to an 
increase in the number of Bacteroiodetes, gram negative bacteria in the gut, 
which, if they enter circulation, trigger an inflammatory response (Moise, The Gut 
Microbiome.). The intestinal wall serves as an important barrier between the 
external factors and the body. If this wall becomes weak, pathogens or gut flora 
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may be able to enter systemic circulation and trigger an inflammatory response 
(Moise, The Gut Microbiome.). Possible pathways for immune system 
communication with the brain are by cytokines directly acting on the vagus nerve, 
or by getting into systemic circulation and crossing weak parts of the blood brain 
barrier (Lyte and Cryan).  
 Research shows that inflammatory diseases and increased inflammation 
are associated with cognitive impairment (Bartolini et al., 2002; Elfferich et al, 
2010; Raftery et al., 2012). Patients who have sarcoidosis, an inflammatory 
disease, often complain of cognitive impairment. Compared to healthy age and 
sex matched controls, patients with sarcoidosis show significantly higher 
prevalence of daily cognitive failure as measured with a questionnaire to assess 
everyday decreases in attention, perception, and memory (Elfferich et al., 2010). 
After this baseline questionnaire, patients were either untreated, or treated with 
anti-Tumor Necrosis Factor (TNF)-alpha. When patients were retested with the 
same cognitive function questionnaire after six months of treatment the group 
who was given anti-TNF-alpha treatment displayed significantly improved 
cognitive function while the other two groups did not (Elfferich et al., 2010). 
Similar results were seen in rheumatoid arthritis patients who showed significant 
improvements in IQ tests after TNF-alpha treatment compared to their baseline 
performance before treatment (Raftery et al., 2012). It is possible that the 
cognitive function improved as a result of the decreased inflammation, and 
implies that inflammation may contribute to cognitive decline. In a mouse model 
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induction of systemic inflammation, increased inflammatory cytokines in aged 
mice corresponded with a decrease in cognition (d’Avila et al., 2018). After 
initiation of systemic inflammation, aged mice showed a decreased performance 
on a novel object recognition test and the Morris Water Maze (MWM), indicating 
reduced non-spatial and spatial memory (d’Avila et al., 2018). Some research 
suggests that systemic inflammation is not associated with memory loss, but that 
inflammatory gastrointestinal diseases are closely related to cognitive decline 
(Castaneda et al., 2013). When compared to aged matched patients with 
idiopathic arthritis, adolescents with IBD showed significantly lower verbal 
memory, as measured with the California Verbal Learning Test (Castaneda et al., 
2013). Therefore inflammation specifically communicating through the gut-brain 
axis may have greater effects on cognition than general systemic inflammation. 
Gastrointestinal infections have been associated with declines in cognition (Eppig 
et al., 2010; Nokes et al., 1991). Eppig et al. (2010) found that prevalence of 
infectious disease in different regions of the world to be the greatest predictor of 
IQ, even ahead of education level. In a study of Jamaican school children, those 
with a Tricuris trichiura, or whipworm, infection displayed decreased cognition 
compared to uninfected individuals (Nokes et al., 1992). Cognitive function was 
assessed using four tests: the digit-span test for auditory-short term memory, the 
fluency language test for motivation, retrieval, and scanning of long term 
memory, the listening comprehension test for auditory short term memory and 
information processing, and the matching familiar figures test as an assessment 
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for problem solving abilities. After treatment and eradication of the whipworm 
infection, children were retested with all four assessments and found to have 
significantly improved in the language fluency test and the digit-span tests when 
compared to improvements in the uninfected controls (Nokes et al., 1992). The 
gastrointestinal infection of Tricuis trichiura likely caused decreased cognition in 
regards to scanning and retrieving long-term memory as well as auditory short-
term memory. These studies highlight the importance of gastrointestinal diseases 
on cognition. While more studies should be performed to decipher the exact 
mechanism through which gut inflammation and infection decrease cognition, it is 
possible that inflammatory cytokines communicate with the brain either by 
directly acting on the vagus nerve or by circulating in blood and eventually 
crossing the blood brain barrier (Bercik et al., 2010; Bercik et al., 2011; Lyte and 
Cryan). Increased immune system activation and inflammation are often 
associated with decreased cognition, and inflammation is related to many other 
levels of the GBA such as presence of short chain fatty acids (SCFA), brain 
derived neurotrophic factor (BDNF) expression, and hormonal signaling, which 
are discussed in detail throughout this paper.  
The Gut Microbiome and Cognition 
The gut microbiome effects all levels of the gut-brain axis and is closely 
related to cognitive function. Humans generally have a commensal relationship 
with gut bacteria, as the bacteria is able to digest food that humans cannot and 
promote health by producing beneficial metabolites and hormones, though this is 
 13 
not always the case (Moise, The Gut Microbiome.). The composition of the gut 
microbiome begins to be established before birth, is affected by early life events, 
stays relatively constant through adulthood, and changes with old age 
(Leniewska et al., 2006; Lyte and Cryan; Moise, The Gut Microbiome.). The gut 
microbiome reflects early life events and infants who are born by caesarean 
section have significantly different microbiota compositions than those delivered 
vaginally. However, after about one year, there is no significant difference in 
composition, as the microbiome naturally stabilizes (Moise, The Gut 
Microbiome.). The gut microbiome is predominantly composed of bacteria in the 
phyla Bacteroidetes and Firmicutes (Moise, The Gut Microbiome.). The ratio of 
bacteria in these phyla remains relatively constant throughout life, unless 
modified by environmental changes, but changes spontaneously in older adults 
for reasons which are not yet completely understood (Lesniewska et al., 2006; 
Lyte and Cryan, Microbial Endocrinology.). Elderly rats have a significantly 
different gut microbiome composition when compared to adult rate (Lesniewska 
et al., 2006). Generally, older individuals tend to have an increase in the number 
of Bacteroidetes and a decrease in the number of Firmicutes, which could 
correspond to age related neurological changes such as cognitive decline 
(Moise, The Gut Microbiome.). While the overall number of bacteria remains 
stable with age, elderly individuals generally have a less diverse gut microbiome 
and adults (Lyte and Cryan, Microbial Endocrinology.). While the microbiome 
stabilizes at a young age and remains relatively stable throughout life, the gut 
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microbiota diversity decreases and the composition changes in elderly adults, 
revealing a possible cause for age related cognitive decline.         
In addition to these natural changes that occur with time, the gut 
microbiome can also be modified by treatment with antibiotics, probiotics, 
prebiotics, and diet modifications (Chunchai et al., 2018; Moise, The Gut 
Microbiome.; Zhang et al., 2012,). Antibiotics, often used as treatments for 
pathogenic infections, also eliminate beneficial bacteria and alter the microbiome 
in a negative way. Treatment with antibiotics is known to decrease both the 
number of bacteria in the gut as well as the diversity of the gut flora (Fröhlich et 
al., 2016). After just a single week of treatment with antibiotics, the microbiome 
may remain altered for about one year (Moise, The Gut Microbiome.). 
Conversely, treatment with prebiotics and probiotics are thought to modify the gut 
microbiome in a positive manner (Chunchai et al., 2018). Prebiotics are ingestible 
components that nourish beneficial bacteria in the gut, and promote the growth of 
more beneficial bacteria. Probiotics consist of live bacteria that contribute to a 
healthy gut and increase diversity in the gut flora (Moise, The Gut Microbiome.). 
In a study of Vietnamese children, those who drank milk fortified with probiotics 
showed a significant increase in the number of gut bacteria compared to those 
who drank milk without probiotics. This change in the microbiome corresponded 
to an improved quality of life (Lien et al., 2009). The composition of gut 
microbiota may also change on a daily basis depending on diet. In a human 
study, subjects were fed controlled diets that were either high in fat and lower in 
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fiber, or high in fiber and low in fat and changes in the microbiome composition 
were noted after just twenty-four hours (Wu et al., 2011). Consumption of a high 
fiber diet was associated with an increase in the number of Firmicutes and a 
decrease in the number of Bacteroidetes, while a high fat diet was associated 
with an increase in the number of Bacteroidetes and a decrease in the number of 
Firmicutes (Wu et al., 2011). A high fiber diet is essential to a healthy gut 
microbiome, as humans cannot digest fiber so it serves as nourishment for gut 
bacteria and promotes healthy bacterial growth (Moise, The Gut Microbiome.). 
Interestingly, the change in composition, an increase in the Bacteroidetes to 
Firmicute ratio, seen with a high fat diet also occurs naturally with age (Moise, 
The Gut Microbiome.). This brings up the possibility that a high fat diet (HFD) has 
the potential to promote this change at an early age, while a high fiber diet may 
do the opposite. High fat diets cause decreases in both the diversity of the gut 
microbiome and the overall number of gut bacteria, and have been associated 
with anxiety, mood disorders, and decreased cognition (Zhang et al., 2012). The 
gut microbiome is negatively affected by treatment with antibiotics and high fat or 
western diets, and may be beneficially modified with probiotics, prebiotics, and a 
high fiber diet.  
Modifications of the microbiome communicate with the CNS through the 
GBA and may positively or negatively affect cognition. Gut dysbiosis may act on 
cognition in a variety of ways including inflammation, oxidative stress, and 
hormones (Chunchai et al 2018). Chunchai et al. (2018) found that rats who 
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consumed a HFD experienced gut dysbiosis. For example, a HFD is associated 
with an increase in the Firmicute to Bacteroidetes ratio. When rats who 
consumed the HFD were treated with prebiotics or probiotics, the ratio of 
Firmicutes to Bacteroidetes decreased when compared to HFD rats who 
received a placebo, suggesting that these treatments corrected the dysbiosis 
caused by a HFD. Furthermore, Chunchai et al. (2018) explored the correlation 
of this change in microbiome to hippocampal long-term potentiation (LTP) and 
spatial memory. They measured LTP in hippocampal slices and found that rats 
who consumed the HFD and were treated with the vehicle showed lower 
dendritic spine density and reduced LTP compared to rats that consumed a 
regular diet and those who consumed a HFD but were treated with prebiotics or 
probiotics. Additionally, rats who consumed a HFD and were treated with a 
vehicle displayed decreased spatial memory when compared to rats that ate a 
standard diet (Chunchai et al., 2018). However, after twelve weeks of treatment 
with either prebiotics or probiotics, rats showed a significant improvement in 
cognition and performance in the MWM when compared to rats who received the 
vehicle (Chunchai et al 2018). There was no difference in locomotion between 
any of the groups, so these results were not simply due to a change in motor 
activity. This suggests that possibility that gut dysbiosis may cause a decline in 
spatial memory, while a correction of the gut microbiome composition with 
probiotic or prebiotic treatments may improve memory.  
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Diet has been found to change not only the composition of the gut flora, 
but the diversity of the flora as well (Li et al., 2009; Zhang et al., 2012). When 
rats were fed a mixture of their standard food supplemented with 50% ground 
beef, they had a greater diversity of gut microbes when compared to animals that 
ate only their standard food (Li et al., 2009). The beef diet was significantly 
higher in fat than the standard pellet powder as the beef diet contained 33% fat 
while the pellet powder contained 12% fat. Rats who consumed the beef diet 
showed reduced anxiety, increased working memory, and increased reference 
memory when compared to animals that ate the standard pellet powder (Li et al., 
2009). These results are inconsistent with previous studies that show a high fat 
diet is correlated with a decrease in diversity of the gut flora and impaired 
cognition (Chunchai et al., 2018, Zhang et al., 2012). These differences may 
have occurred for multiple reasons including the fact that the HFD and control 
diets may have had additional nutritional differences that were not explicitly 
stated. Also, the percent of calories from fat in the HFD and control diets varied 
between experiments. Li et al. (2009) used a HFD that was about 33% fat and a 
control diet that was about 12% fat, Chunchai et al. (2018) used a HFD that was 
about 60% fat and a control diet that was about 19% fat, and Zhang et al. (2012) 
used a HFD that was about 33% fat and control diet that was about 5% fat. Thus, 
the differences in experimental results could have occurred not because of the 
differences in the total percentage of fat in the HFD, but because of the 
differences in percentages between the HFD and the control diets. However, all 
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three experiments do support the hypothesis that a change in diet changes the 
diversity of the gut microbiome.  
Long-term consumption of a Western Diet (WD) has the potential to cause 
many other health issues, such as insulin resistance, high cholesterol, and 
cardiovascular disease, which may also impact cognition, making it difficult to 
draw direct correlations between the WD and cognition. However, in rats, 
Kanoski and Davidson (2010) observed memory decline after just three days of 
consuming a western diet. After three days of consuming a diet high in saturated 
fat and simple carbohydrates, rats displayed reduced spatial memory as 
measured by their performance in the radial maze and the Morris Water Maze 
(Kanoski and Davidson, 2010). This provides evidence that changes in cognition, 
particularly spatial memory, are directly related to the diet and microbiome 
composition. Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease 
(IBD) are two naturally occurring models of gut dysbiosis. Patients with IBS and 
IBD perform poorly on verbal intelligent quotient (IQ) test compared to healthy 
individuals (Dancey et al., 2009). Additionally, IBS patients display decreased 
cognitive flexibility. In a human study, patients with IBS were found to have 
decreased cognitive flexibility, as assessed with the Wisconsin Card Sorting Test 
(Aizawa et al., 2012). IBS patients also showed decreased hippocampal 
activation during the assessment, supporting the idea that gut dysbiosis is 
associated with decreased hippocampal activation and decreased cognition 
(Aizawa et al., 2012). However, some studies disagree with this concept. In an 
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observational study of 150 patients with IBD, 40 patients with IBS, and 41 healthy 
controls, IBD and IBS patients appeared to score lower on fluid intelligence tests 
than healthy controls, while there was no significant difference in performance on 
memory for inference tests. However, once the results were adjusted to remove 
depression as a variable, the differences in fluid intelligence became non-
significant (Berrill et al 2013). This study disagrees with other experiments which 
correlate gut dysbiosis with impaired memory. Perhaps, memory impairment 
results from other underlying psychological disorders such as depression or 
anxiety, which may or may not be caused by gut dysbiosis. 
Some changes in the microbiome may be associated with improved 
cognition. Treatment with probiotics changes the gut flora in a beneficial way and 
has been associated with improved cognition (Chunchai et al, 2018). Treatment 
with probiotics modifies the composition of the gut flora and is associated with 
increased LTP in an age dependent manner (Distrutti et al 2014). In aged rats, 
probiotic treatment significantly increased the prevalence of bacteria in the phyla 
Bacteriodetes and Actinobacteria when compared to aged controls (Distrutti et al 
2014). However, in young rats, probiotics did not significantly alter the 
microbiome. These results may be related to the fact that the microbiome 
composition spontaneously changes throughout the lifetime (Distrutti et al, 2014; 
Moise, The Gut Microbiome.). Additionally, probiotics did not significantly 
increase LTP in young rats, but significantly increased hippocampal LTP in aged 
rats when compared to aged rats who did not receive probiotics (Distrutti et al, 
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2014). Other studies suggest that probiotics improve memory regardless of age 
(Matthews and Jenks, 2013). Mice who were treated with probiotics displayed 
improved spatial memory, as measured by completing a maze faster, compared 
to controls. However, after a washout period of one week, there was no 
significant difference in performance between groups (Matthews and Jenks, 
2013). This provides further evidence that changes in the microbiome are closely 
related to changes in memory, as an acute change in the microbiome has the 
ability to improve memory, but the improvement decreases after the microbiome 
returns to its stable state.  
Brain Derived Neurotrophic Factor 
One of the possible mechanisms through which an alteration of the 
microbiome affects cognition is through expression of brain derived neurotrophic 
factor (BDNF). BDNF is an important neurotrophin that is known to be involved in 
neuronal development, growth, plasticity, learning and memory, depression, and 
anxiety (Bercik et al, 2011; Lyte and Cryan). Studies show that BDNF levels, 
specifically hippocampal BDNF levels, can be altered with changes in the gut 
microbiome (Heijtz et al, 2011; Savignac et al, 2013). Germ free mice show 
reduced expression of BDNF in the cortex, hippocampus, and amygdala (Heijtz 
et al, 2011). Additionally, rats treated with prebiotics showed an increase in 
number of Bifidobacteria as well as an increase in hippocampal BDNF 
expression compared to controls, though plasma BDNF levels did not change 
with prebiotic treatment (Savignac et al, 2013). This implies that a change in gut 
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flora composition may specifically impact BDNF in the brain without impacting 
global levels. However, when human cells were incubated with plasma from rats 
treated with prebiotics, there was a nonspecific increase in BDNF release when 
compared to cells incubated in plasma from rats not treated with prebiotics 
(Savignac et al, 2013). While the mechanism through which microbiota in the gut 
affect BDNF expression is not well established, it is evident that there is a 
connection between the gut microbiome and BDNF expression. This could be 
one way in which the gut microbiome is associated with cognition.  
Alterations in the gut microbiome have been documented to be associated 
with alterations in BDNF expression and cognition. GF mice display decreased 
non-spatial and spatial memory as tested with novel object recognition tests and 
the T maze, as well as reduced levels for hippocampal BDNF and c-Fos 
hippocampal expression when compared to controls (Gareau et al, 2011). 
Furthermore, gut dysbiosis has been associated with cognitive impairment and a 
change in BDNF expression. After antibiotic treatments hippocampal BDNF 
mRNA expression is decreased (Fröhlich et al 2016). In addition to causing 
changes in the gut microbiome, a high fat diet also alters BDNF expression 
(Chunchai et al, 2018; Li et al, 2009; Molteni et al, 2002). Rats who consume a 
high fat and sucrose (HFS) diet show decreases in hippocampal BDNF mRNA 
expression after being on the diet for two to twenty four months when compared 
to controls. The lowest values were seen at 24 months, indicating that the BDNF 
expression changes could be time dependent, with a longer diet causing more 
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damage (Molteni et al., 2002). Spatial memory is impaired at both one and two 
months after starting a HFS diet when compared to controls, as tested with the 
Morris Water Maze (Molteni et al., 2002). In this experiment, rats on the HFS diet 
were not significantly heavier than controls until twenty five weeks and did not 
show hypertension or other physiological deficits including insulin resistance until 
twelve months on the diet, so it is unlikely that the memory impairment came 
from another source (Molteni et al., 2002). However, increased BDNF mRNA 
expression is not always associated with improved cognition, or vice versa. For 
example, though probiotics were only found to increase LTP in aged rats, both 
young and aged rats treated with a probiotic showed significantly higher BDNF 
mRNA expression than controls, suggesting that BDNF expression is not always 
associated with improved cognition (Distrutti et al, 2014). Though memory and 
BDNF mRNA expression do not always have a positive correlation, this does 
support the idea that a change in the gut microbiome is correlated with a change 
in BDNF expression.  
The mechanism through which an alteration in the microbiome alters 
hippocampal BDNF mRNA expression is not known, but it is hypothesized that it 
may be through oxidative stress (Wu et al., 2004). Wu et al explored the 
connection between diet, BDNF, and memory. Rats that ate a HFD showed 
increased levels of hippocampal oxidative proteins and oxidized amino acids, 
which were decreased with vitamin E, a known antioxidant (Wu et al, 2004). In 
agreement with previous studies, rats who consumed a HFD showed decreased 
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levels of BDNF mRNA expression (Molteni et al., 2002; Wu et al., 2004). 
Treatment with vitamin E, which reduced oxidative stress, also increased BDNF 
mRNA levels in rats who consumed a HFD. Vitamin E alone did not significantly 
change BDNF mRNA expression, so these results were not due to vitamin E 
acting directly on BDNF, but were more likely due to its properties as an 
antioxidant (Wu et al., 2004). Additionally, rats who consumed a HFD showed 
decreased memory compared to controls that ate regular diets, as measured by 
the MWM. However if rats who consumed a HFD were treated with vitamin E, 
they performed similarly in the water maze to rats who consumed a regular diet 
(Wu et al, 2004). This suggests a relationship between the microbiome, oxidative 
stress, BDNF mRNA expression, and memory.  
The immune system is another possible pathway through which the gut 
communicates with the brain and modifies BDNF expression. Gareau et al. 
(2011) investigated the effects of the gut microbiome on hippocampal BDNF 
levels and memory. When mice were infected with Citrobacter rodentium, a 
pathologic bacteria, they were observed to have altered gut microbiomes, colonic 
inflammation, memory, BDNF express, and c-Fos expression (Gareau et al., 
2011). The infected group displayed higher levels of colonic pro-inflammatory 
cytokines as well as a change in the composition of gut microbiota, both of which 
returned to baseline after treatment with probiotics. Mice infected with C. 
rodentium alone did not display a decrease in non-spatial or spatial memory 
compared to controls, as tested with NOR or T-maze tests. However, if infected 
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mice were exposed to Water Avoidance Stress, they performed significantly 
lower on both tests of cognition when compared to controls and non-stressed 
animals. These behavioral changes could be attenuated by treatment with a daily 
probiotic (Gareau et al., 2011). Additionally, infected mice who were exposed to 
stress displayed lower levels of hippocampal BDNF and c-Fos compared to 
controls, though, levels of both BDNF and c-Fos in infected animals treated with 
probiotics were similar to non-infected control animals. This study demonstrates 
that probiotics, which positively modify the gut microbiome, have the ability to 
improve memory in animals that have been exposed to infection and stress, 
possibly through the restoration of BDNF and c-Fos to normal levels.  
Short Chain Fatty Acids  
 When intestinal bacteria digest nutrients they produce byproducts. These 
metabolites may be a mechanism through which the gut microbiome 
communicates with the brain (Lyte and Cryan; Moise, The Gut Microbiome.). 
Short chain fatty acids (SCFA), specifically acetate, butyrate, and propionate, are 
the main metabolites that result from bacterial fermentation of carbohydrates 
(Moise, The Gut Microbiome.). These end products have the potential to enter 
systemic circulation where they can communicate with the immune system and 
the central nervous system, and, possibly, influence cognition (Lyte and Cryan). 
Butyrate is more readily absorbed by the intestinal cells, while propionate and 
acetate are more likely to enter systemic circulation (Moise, The Gut 
Microbiome.). The levels of circulating and cecal SCFA have been documented 
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to change with alterations in the microbiome that may be caused by diet, 
probiotics, or antibiotics, while the concentrations of SCFA may also influence 
the microbiome (Fröhlich et al, 2016; Ohland et al, 2013; Moise, The Gut 
Microbiome.). This may occur because different intestinal bacteria are known to 
produce SCFA. For example, butyrate is often a metabolite of Firmicute 
fermentation of indigestible, or resistant, starches, which often come from high 
fiber diets (Moise, The Gut Microbiome.). When more butyrate is present in the 
intestine, it lowers the pH of the intestinal lumen and promotes the growth of 
more butyrate-producing cells, which prefer this lower pH (Moise, The Gut 
Microbiome.). Therefore, it is reasonable to think that a high fiber diet has the 
potential to change the microbiome by promoting the growth of more Firmicutes. 
However, this is not always the case. In a study on twenty five human subjects, 
those who consumed a test drink composed of glucose and resistant starches 
did not show significantly higher levels of serum SCFA when compared to the 
control group who drank only glucose (Rahat-Rozenbloom et al., 2017). This 
could have occurred because, as butyrate may be absorbed or utilized as an 
energy source by intestinal cells, serum concentrations of SCFA may not be 
reflective of intestinal concentrations. However, Rahat-Rozenbloom et al. (2017) 
did find that treatment with glucose and inulin, a prebiotic, did correspond with 
significantly higher serum levels of SCFA when compared to those treated with 
glucose and resistant starch or just glucose. While a high fiber diet may not 
always increase serum concentrations of SCFA, there is evidence that a western 
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diet, high in fat and carbohydrates, decreases cecal levels of SCFA (Ohland et 
al., 2013). Mice who consumed a western diet consisting of 33% fat and 49% 
carbohydrates showed decreased levels of cecal SCFA when compared to mice 
who consumed standard rodent chow. In this case, treatment with the probiotic 
Lactobacillus helveticus was able to normalize the gut microbiomes of the mice 
fed the WD so they resembled the control group, this change in microbiome 
composition was not accompanied by an increase in cecal levels of SCFA 
(Ohland et al., 2013). While there are disagreements in the literature about what 
exact changes in the microbiome influence serum or cecal levels of SCFA, it is 
clear that there is a relationship between the change in the microbiome and 
SCFA production.  
 This change in SCFA production has been associated with changes in 
cognition. Fröhlich et al. (2016) observed a correlation between gut dysbiosis, 
SCFA concentration, and cognitive impairment. Mice treated with had a less 
diverse gut microbiome as well as fewer intestinal bacteria, a decrease in colonic 
levels of SCFA, and impaired spatial memory as measured with NOR test 
(Fröhlich et al., 2016). Additionally, antibiotic treated mice showed decreased 
hippocampal and amygdala expression of tight junction proteins, implying the 
SCFA may be partially responsible for maintaining tight junctions. A decrease in 
hippocampal BDNF mRNA expression was also seen in mice after antibiotic 
treatment, and, as previously discussed changes in BDNF expression could be a 
link between the microbiome and cognitive changes (Molteni et al., 2002). It is 
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unlikely the SCFA directly change levels of BDNF (Grider and Piland, 2007). 
When SCFA are added to the central compartment a rat colonic preparation, 
there is a significant eight fold increase in the release of serotonin and but so 
change in BDNF release (Grider and Piland, 2007). This implies that it is unlikely 
that SCFA directly change BDNF expression to modify memory, but may do so 
through other humoral factors such as serotonin, which will be discussed later.  
 Short chain fatty acids may more directly influence cognition through their 
role as histone deacetylase (HDAC) inhibitors. Histone acetylation relaxes 
condensed chromatin and favors gene transcription, while deacetylases favor 
condensed chromatin and prevent gene transcription (Blank et al., 2015). Histone 
acetyl transferases (HAT) act to acetylate the lysine residues of histones while 
HDACs act to deacetylate them. HDAC inbitors prevent the deacetylation of 
histones, thereby favoring gene transcription, and have been known to be 
involved in memory formation (Alarcón et al., 2014; Blank et al., 2015). The 
SCFA butyrate can act as an HDAC inhibitor (Schroeder et al., 2017). In mice, 
hippocampal and cortical histone acetylation is significantly increased after and 
injection of sodium butyrate compared to controls (Schroeder et al., 2007). Lack 
of histone acetylation has been seen as a biomarker for memory decline in 
elderly mice, while increased histone acetylation has been known to improve 
memory (Blank et al., 2015; Peleg et al., 2010). After contextual fear 
conditioning, a test for hippocampal dependent associative memory, three month 
old mice showed significant upregulation of “learning regulated genes” while 
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sixteen month old mice did not. Though basal activity levels of HATs and HDACs 
are similar in three month old and sixteen month old mice, after conditioning, 
histone acetylation, specifically acetylation of histone (H) 4 lysine (K) 12 in 
upregulated genes was significantly lower in aged mice relative to young adults 
(Peleg et al., 2010). The decrease in hippocampal dependent memory in aged 
mice is at least partially due to the decrease in H4K12 acetylation and the 
resulting decreased in gene transcription. When aged mice were injected with an 
HDAC inhibitor they showed significant increases in hippocampal H4K12 
acetylation in “learning-regulated genes” that corresponded to an increase in 
associative learning during contextual fear conditioning, as compared to age 
matched mice who received a vehicle (Peleg et al., 2010). This is consistent with 
the idea that inhibiting histone deacetylation is sufficient to restore age related 
memory decline. Blank et al. (2015) explored the concept of butyrate specifically 
acting as an HDAC inhibitor and improving memory in elderly rats. Elderly rats 
who received an intraperitoneal injection of sodium butyrate after a single trial of 
inhibitory avoidance training showed improved memory retention of the training 
compared to age matched rats who received saline injections. Additionally, the 
elderly rats that received sodium butyrate showed generally higher levels of H3 
acetylation, which has been previously related to memory formation (Blank et al., 
2015, Levenson et al., 2004). This same trend was not seen in younger rats that 
underwent the same experiment, as there was no difference in performance on 
the inhibitory avoidance test between young rats who received sodium butyrate 
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and young rats who received saline injections (Blank et al., 2015). Sodium 
butyrate, acting as an HDAC inhibitor is able to improve memory in aged rats, but 
not young adult rats. Histone acetylation has also been implicated in 
consolidating and strengthening memories. In crabs undergoing context-signal 
memory (CSM) tests, a significant increase in H3 acetylation was not observed 
after weak training, but was observed after longer training, implicating H3 
acetylation in the consolidation process of strong memories (Federman et al., 
2009). Additionally, if crabs were treated with saline they did not display long 
term memory after weak training with CSM, as crabs who had previously 
received weak training did not perform better than crabs who did not receive any 
training. However, if crabs received sodium butyrate injections prior to weak 
training they were able to form long term memories, implicating sodium butyrate 
in consolidation and strengthening of memories (Federman et al., 2009). Short 
chain fatty acids, specifically butyrate, communicate between the brain and the 
gut by acting directly on the CNS as HDAC inhibitors, thereby promoting gene 
transcription and improving memory.        
 Another possible mechanism for SCFA contributing to cognition is 
indirectly through the immune system. As previously discussed, inflammation and 
changes in the immune system have been associated with cognitive impairment 
(Elfferich et al., 2010; Faraco et al., 2018; Raftery et al., 2012). SCFA may have 
protective effects for cognition by protecting the intestinal barrier and decreasing 
inflammation (Finnie et al., 1995; Ma et al., 2015; Moise, The Gut Microbiome.). 
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Butyrate decreases inflammation both through increasing the number of T 
regulatory cells, which inhibit inflammation through their production of IL-10 
(Moise, The Gut Microbiome.). In addition to its known anti-inflammatory effects, 
Butyrate is known to have protective effects against intestinal dysbiosis and 
damage through increasing mucus production and protecting the intestinal 
epithelium (Finnie et al., 1995; Moise, The Gut Microbiome.). SCFA, specifically 
butyrate, may indirectly protect cognition by decreasing inflammation and 
promoting intestinal barrier strength to protect the body from infection and 
immune system activation which has the potential to negatively influence 
cognition.  
 Short chain fatty acids are metabolites from bacterial fermentation that 
occurs in the gut and have been implicated in affecting cognition. Levels of SCFA 
change in response to gut flora modifications and have the ability to change the 
composition of the gut micriobiome. These metabolites of the gut micriobiota are 
a pathway by which the gut and the brain communicate and have the potential to 
improve memory by directly acting on the CNS as HDAC inhibitors or indirectly 
protecting memory by strengthening the gut immune system and decreasing 
inflammation.       
Ghrelin and Cognition 
 Ghrelin is a twenty eight amino acid acylated peptide hormone that is 
produced by enteroendocrine cells in the stomach. It is classically known as an 
appetite stimulating hormone as it antagonizes the effects of leptin, an appetite 
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suppressing hormone, in the hypothalamus (Waseem et al., 2009). It is well 
established that the release of ghrelin is related to food consumption and energy 
homeostasis, as ghrelin levels increase when the body needs energy and 
decrease after food consumption. More recently, ghrelin has been researched 
due to its involvement in other body systems, including the reproductive system, 
the cardiovascular system, and the immune system (Waseem et al., 2009). 
Ghrelin is an example of how the gut and the brain communicate using humoral 
pathways and may be a hormone through which changes in the gut may affect 
cognition.     
 Changes in the microbiome have been associated with changes in plasma 
ghrelin levels (Queipo et al, 2013; Yanagi et al, 2017), though the research is 
inconsistent. Eradication therapy of H. Pylori using antibiotics is known to affect 
the microbiome composition and plasma ghrelin levels (Yanagi et al., 2017). 
Three months after eradication therapy, which consisted of two antibiotics and a 
proton pump inhibitor twice per day for seven days, the composition of gut 
microbiota had changed significantly, showing an increase the number of 
Bacteroidetes and a decrease in the number of Firmicutes. Additionally, Yanagi 
et al. (2017) found that plasma levels were significantly lower and correlated an 
increase in the number Bacteroidetes and a decrease in number of Firmicutes 
with a decrease in plasma concentrations of ghrelin. However, Queipo et al. 
(2013) found serum ghrelin levels to increase with an increase in the number of 
Bacteroides. Additionally, Rahat-Rozenbloom et al. (2017) found serum 
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concentrations of ghrelin to be decreased with an increase in SCFAs, which are 
often produced by Firmicutes. However, serum concentrations of SCFAs may 
also be altered by diet and other factors, and are not necessarily indicative of a 
certain microbiome composition or increases in the number of Firmicutes. While 
it is unclear what exact compositions of the gut microbiota promote and increase 
or decrease in ghrelin secretion, it is evident that changes in the gut, from either 
consuming food or modifying the microbiome are related to changes in serum 
ghrelin concentrations.  
 Ghrelin has been implicated with changes in memory and is a possible 
hormone through which the gut and the brain communicate. In human study that 
assessed adults ages 65-85 years old, those with cognitive impairment, as 
determined by the Mini-Mental Status Exam (MMSE), Montreal Cognitive 
Assessment (MoCA) and a short term memory recall test, had significantly lower 
fasting levels of ghrelin that participants who did not show cognitive impairment 
(Sang et al., 2018). Additionally, scores on the short term memory recall test 
were positively correlated with ghrelin levels (Sang et al., 2018). These results 
suggest that the ghrelin may either improve cognition or has protective effects 
that prevent cognitive impairment.  
 Ghrelin may indirectly protect the brain from cognitive impairment by 
impacting the immune system and reducing inflammation. Ghrelin has been 
shown to exhibit anti-inflammatory effects in rodents (Bansal et al., 2010; Wei et 
al., 2015). In a mouse model of traumatic brain injury, mice who received ghrelin 
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treatments had significantly less systemic inflammation and decreased intestinal 
permeability compared to controls who did not receive ghrelin (Bansal et al., 
2010). In a rat model of sepsis, induced by cecal ligation and puncture (CLP), 
septic rats show decreased cognition as assessed with NOR test and a 
continuous multiple trial inhibitory avoidance task (Wei et al., 2015). However, 
performance on both tests was significantly improved if CLP rats received ghrelin 
treatment. Additionally, CLP rats who received ghrelin treatment had significantly 
lower hippocampal levels of the pro-inflammatory markers TNF-alpha and IL-6 
compared to CLP rats who did not receive ghrelin. Ghrelin treated rats were also 
noted to have decreased hippocampal levels of apoptotic markers compared to 
CLP rats who did not receive ghrelin (Wei et al., 2015). Since increased 
apoptosis is associated with increased inflammation, it is difficult to discern from 
this study whether ghrelin acts on the CNS or on the immune system, and there 
has been research in both areas. Ghrelin acts on growth hormone secretagogue 
receptors, which have been found on lymphocytes, neutrophils, and 
macrophages (Waseem et al., 2009). By acting on these receptors, ghrelin has 
the ability to decrease inflammation by promoting the release of anti-
inflammatory cytokines, such as IL-10, and inhibiting the release of pro-
inflammatory cytokines, such as TNF-alpha (Waseem et al., 2009). Ghrelin may 
act through the immune system to promote communication between the gut and 
the brain.   
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It is also possible that ghrelin works directly on the CNS to improve 
cognition. Compared to WT mice, ghrelin knock-out (KO) mice display 
significantly decreased hippocampal cell proliferation, which increased after 
ghrelin treatment (Li et al., 2013). This decrease in hippocampal cell proliferation 
was associated with decreased spatial and non-spatial memory in ghrelin KO 
mice, as measured with the NOR test and the Y maze, as compared to WT mice. 
After ghrelin treatment, ghrelin KO mice showed increased spatial and non-
spatial memory compared to pretreatment, and did not perform differently WT 
mice on either behavioral test (Li et al., 2013). Human functional magnetic 
resonance imaging (fMRI) studies support the idea that ghrelin may directly act 
on the CNS (Kunath et al., 2016). Human subject who received ghrelin injections 
showed significantly different brain circuitry patterns compared to controls, 
specifically with increased activity in the occipital cortex, right lingual gyrus, and 
right fusiform gyrus, when compared to the placebo group. However, this change 
in CNS connectivity was not accompanied by a change in cognition, as there was 
no significant difference between groups on cognitive tasks assessing working 
memory, fluid reasoning, creativity, reaction time, or attention (Kunath et al., 
2016). While this supports the idea that ghrelin directly modifies neuronal 
proliferation or connectivity, it also shows that such changes at a cellular level 
are not always directly associated with behavioral changes. Ghrelin, whose 
production in the stomach changes with food consumption and the gut 
microbiota, is associated with increased cognition, while low serum ghrelin 
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concentrations may be a marker for cognitive decline. Ghrelin may affect 
cognition either indirectly through anti-inflammatory effects and by directly 
modulating neuronal proliferation and connectivity. The gut brain axis may use 
ghrelin as a pathway of communication, ultimately affecting memory and 
cognition. 
  
Serotonin and Cognition  
Serotonin, an amine that functions as a neurotransmitter in diverse roles in 
the GI system and the CNS, represents a pathway for the communication 
between the gut and the brain. Serotonin is classically thought to be involved in 
mood, but more recent studies show it is also involved in the GI system and 
cognition. The enteroendocrine cells in the gut produce a large amount of 
serotonin and alterations in the gut microbiome alter the amount of serotonin 
available in the brain (Clarke et al., 2013; Kilkens et al., 2004). Interestingly, both 
GF mice and mice treated with probiotics are noted to have increased levels of 
tryptophan and central serotonin (Desbonnet et al., 2008; Clarke et al., 2013). 
This idea does not follow the trend that usually probiotic treatments have the 
opposite effects of a lack of microbiome in GF mice. Additionally, mice treated 
with probiotics show decreased levels of 5-Hydroxyindoleacetic acid, the main 
metabolite of serotonin, indicating a decrease of serotonin degradation in the 
brain (Lyte and Cryan). This indicates that modifications of the microbiome may 
be involved in both increasing serotonin production and decreasing degradation. 
The mechanisms by which the microbiome mediates central serotonin levels 
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needs more investigation, though it is evident that there is a relationship between 
modifications of the gut flora and serotonin in the CNS.       
Variations in the gut microbiome, serotonin availability, and excitation of 
serotogenic neurons have been correlated with cognitive changes. In a human 
study, patients with IBS displayed a significantly greater loss of recall memory 
than healthy controls, which corresponds to previous discussions of gut dysbiosis 
correlating with decreased cognition (Kilkens et al., 2004). Additionally, after 
treatment for acute tryptophan depletion, which is known to decrease central 
serotonin, both healthy participants and those with IBS showed decreased recall 
memory (Kilkens et al., 2004). Activation of serotogenic neurons, specifically in 
the hippocampus, is associated with improved cognition (Teixeira et al., 2018). In 
mice, optogenetic activation of serotonergic axon improves spatial memory, while 
optogenetic inhibition of hippocampal serotonergic axon terminals results in 
memory impairment, as assessed by the Morris Water Maze (Teixeira et al., 
2018). An increase in central serotonin concentrations and activation is 
associated with an increase in cognitive function.   
The gut brain axis communicates via serotonergic pathways, which alter 
hippocampal activity and memory. Optogenetic activation of hippocampal 
serotonergic axon terminals results in an increase in hippocampal activity and 
connectivity, while inhibiting the same neurons has the opposite effect (Kilkens et 
al., 2004). Serotonergic activation of the hippocampus is related to memory 
formation, likely in the encoding phase. In a study of healthy males, van de Veen 
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et al. (2006) used fMRI to assess brain activity and used a word recall test to 
assess episodic memory after lowering serotonin availability with acute 
tryptophan depletion. Subjects who had reduced levels of CNS serotonin showed 
decreased right hippocampal activity, specifically during the encoding phase of 
the memory test. This change in hippocampal activity was accompanied by 
decreased memory, as subjects performed poorly, with more errors in 
recognizing previously presented words, after tryptophan depletion compared to 
the control group. There was no difference in mood associated with acute 
tryptophan depletion, therefore, this change in memory and activity is due to 
changes in central serotonin levels and not due to a change in mood (van de 
Veen et al., 2006). Additionally, studies indicate that treatment with probiotics can 
increase serotonin levels and prevent age-related decreases in cognition (Corpuz 
et al., 2018). In a mouse model accelerated senescence, mice who ate a diet 
supplemented with probiotics, specifically Lactobacillus paracasei, for forty-three 
weeks showed better cognition when compared to those that ate a standard 
rodent diet when assessed using the Barnes Maze, the Y-maze, and inhibitory 
avoidance (Corpuz et al., 2018). Furthermore, mice treated with L. paracasei had 
increased levels of central serotonin as well as hippocampal and cortical BDNF 
mRNA (Corpuz et al., 2018). Probiotics, and the resulting increase in serotonin, 
may have protective effects against age related cognitive decline. The gut and 
the brain communicate via the neurotransmitter serotonin, which has the 
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potential to increase cognition by increasing hippocampal activity during the 
encoding phase of memory formation.         
DISCUSSION 
Current literature suggests that the microbiome, gut, and the brain are in 
close communication through the immune system, nervous system, endocrine 
system, and microbial metabolites. Changes in the microbiome, by diet or 
treatment with prebiotics, probiotics, or antibiotics, are associated with changes 
in all levels of the gut-brain axis. Though exact mechanisms of communication 
are not well established, research generally agrees that increases in systemic 
inflammation and gastrointestinal infections are related to cognitive decline (Tsai 
et al., 2018; Bartoli et al., 2002; Toumi et al., 2013; Castadena et al., 2013). The 
GBA is especially difficult to assess because altering one aspect of the GBA, 
such as increasing inflammation, may have widespread effects on that body. 
Therefore, it is difficult to assess if the increased inflammation directly decreases 
cognition, or if it perhaps causes changes is in the microbiome which cause 
cognitive decline. Likely, it is a combination, as all aspects of the GBA are in 
constant bidirectional communication with one another. Investigators support the 
hypothesis that probiotics, prebiotics, and a high fiber diet are associated with a 
healthier and more diverse microbiome, an increase in beneficial metabolites, a 
decrease in inflammation, and improved cognition, while low fiber diets and 
antibiotics have the opposite effects. Modifications of the microbiome may 
decrease cognition by decreasing hippocampal plasticity, as measured with 
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BDNF. Harmful changes to the microbiome may do so by activating the immune 
system, by increasing oxidative stress, or through other mechanisms that may 
not yet be discovered. Likely, BDNF transcription is decreased by numerous 
changes in the body, many of which have not yet been discovered. Additionally, 
beneficial modifications of the microbiome are known to increase concentrations 
of SCFA, which improve memory, likely by acting as HDAC inhibitors and 
providing protective effects against inflammation. Studies generally agree that 
modifications in the microbiome change the amounts of serotonin and ghrelin 
that are available in the brain. It is unclear exactly what modifies these levels, as 
modifications of the microbiome which increase the number of Bacteriodetes 
have been correlated with both increases and decreases in plasma ghrelin 
concentrations. Additionally, increases in plasma tryptophan levels and serotonin 
availability have been associated with both GF mice and probiotic treatments. 
While the exact mechanisms of action are unclear, researchers generally agree 
that increases in both ghrelin and serotonin are associated with improved 
cognition. Further research must be done on the specific changes in the 
microbiome that mediate levels of blood metabolites, decreasing inflammation, 
promoting neurogenesis and plasticity, and positively affecting cognition and 
overall health. 
CONCLUSION 
 
The communication between the gut and the brain is very complicated and 
uses many different pathways. If researchers can identify mechanisms by which 
 40 
changes in the microbiome may improve or protect cognition, they may be able 
to develop treatments to effectively improve memory and decrease the 
prevalence of age-related cognitive decline. Perhaps most obvious from the 
research is the fact that a high fiber diet benefits every part of the gut brain axis 
and improves memory, and that a typical western diet, high in fat and simple 
carbohydrates, is damaging to overall health and cognition. If western societies 
modified their diets there may be a decrease in the prevalence of cognitive 
impairment, which may be a much cheaper and more accessible solution to treat 
or prevent memory decline. Western societies should make an effort to move to 
high fiber diets in order to beneficially modify the gut microbiome, which will 
communicate through the GBA, ultimately improving cognition.   
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